Alliance appoints leader to guide exchange in drug discovery

Dr Ann Hayes has been selected by The European Laboratory Research & Innovation Group (ELRIG) UK and the British Pharmacological Society  to chair their joint steering committee in meeting the objectives of an alliance aiming to bring new opportunities for education and networking in UK drug discovery and pharmacology.

A well-respected member of the drug discovery and pharmacology community with expertise in central nervous system disorders, Dr Hayes has co-founded three drug discovery companies and is on the scientific advisory boards of several others. A former trustee of the British Pharmacological Society, she chaired the industry sub-committee from 2012 to 2015. Prior to this, she spent over 20 years in senior roles at Glaxo (then Glaxo Wellcome), most recently as the Director of Discovery Portfolio. She completed her PhD in Pharmacology at the School of Pharmacy in London.

Dr Del Trezise, ELRIG UK member of the joint steering committee, said: “Dr Hayes’ experience in pharmacology and drug discovery means she is ideally placed to bring together ideas from these complementary fields, helping ELRIG UK and the British Pharmacological Society reach a broad scientific audience.”

Professor Clive Page, President Elect of the British Pharmacological Society and member of the joint steering committee, added: “We look forward to working closely with Dr Hayes to guide our strategic direction. This collaboration marks a new chapter of our history championing innovation in the life sciences and pharmacology.”

For further information about ELRIG UK, please visit: www.elrig.org.

For further information about the British Pharmacological Society, please visit: www.bps.ac.uk